| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
85,734 |
79,186 |
$3.46M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
36,128 |
34,253 |
$2.02M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
53,150 |
51,297 |
$1.29M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
13,798 |
13,085 |
$708K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
13,153 |
12,829 |
$704K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
16,259 |
15,580 |
$559K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
9,374 |
9,210 |
$539K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
19,199 |
18,583 |
$351K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,187 |
5,053 |
$318K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
21,998 |
21,211 |
$229K |
| 92551 |
|
22,412 |
21,792 |
$228K |
| 90461 |
|
18,643 |
18,160 |
$216K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,874 |
5,710 |
$199K |
| 90671 |
|
1,067 |
1,019 |
$157K |
| 90619 |
|
608 |
585 |
$61K |
| 92587 |
|
2,920 |
2,915 |
$56K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
763 |
735 |
$52K |
| 99173 |
|
20,324 |
19,751 |
$49K |
| 90677 |
|
323 |
313 |
$47K |
| 90686 |
|
9,777 |
9,575 |
$46K |
| 36416 |
|
4,609 |
4,387 |
$38K |
| 90670 |
|
2,967 |
2,850 |
$35K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,858 |
1,855 |
$34K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
888 |
863 |
$34K |
| 90651 |
|
707 |
668 |
$30K |
| 99051 |
|
13,965 |
13,506 |
$27K |
| 90716 |
|
1,511 |
1,442 |
$27K |
| 96127 |
|
10,710 |
10,440 |
$25K |
| 90707 |
|
2,143 |
2,050 |
$20K |
| 90700 |
|
7,893 |
7,551 |
$19K |
| 92567 |
|
2,169 |
2,115 |
$17K |
| 90713 |
|
5,970 |
5,715 |
$16K |
| 0071A |
|
236 |
232 |
$9K |
| 90633 |
|
2,826 |
2,713 |
$9K |
| 90656 |
|
1,192 |
1,184 |
$9K |
| 99383 |
|
111 |
110 |
$8K |
| 93000 |
|
529 |
524 |
$7K |
| 0072A |
|
190 |
186 |
$7K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
364 |
351 |
$7K |
| 3008F |
|
795 |
794 |
$6K |
| 90734 |
|
223 |
218 |
$6K |
| 85018 |
|
4,454 |
4,275 |
$5K |
| 90680 |
|
1,973 |
1,870 |
$5K |
| 92558 |
|
1,488 |
1,486 |
$5K |
| 83655 |
|
1,915 |
1,836 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
47 |
47 |
$3K |
| 90648 |
|
4,250 |
4,008 |
$3K |
| 90715 |
|
302 |
295 |
$3K |
| 99384 |
|
38 |
38 |
$3K |
| 90744 |
|
1,684 |
1,599 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
25 |
25 |
$3K |
| 99401 |
|
1,810 |
1,764 |
$2K |
| 96160 |
|
2,822 |
2,732 |
$459.90 |
| 95117 |
|
56 |
43 |
$240.14 |
| 99000 |
|
10,680 |
10,238 |
$141.45 |
| 81002 |
|
260 |
258 |
$111.74 |
| 90647 |
|
280 |
277 |
$97.08 |
| 91307 |
|
464 |
437 |
$56.00 |
| 99072 |
|
15,993 |
14,760 |
$31.50 |
| 99070 |
|
13 |
13 |
$0.00 |